In this webinar, experts will take a deep dive into Delphi panel methods, their implementation, and pharmaceutical industry insights on the panels' uses and outcomes.

For over 15 years, PHAR has conducted RAND/UCLA modified Delphi panels, a systematic and validated way to obtain consensus among clinicians and other experts, such as patient advocates. The speakers plan to broadly present different methods for gaining consensus, including the different Delphi panel approaches that exist, the history of the method’s use, the behavioral science behind why these panels work, how these panels are conducted (both in person and virtually), and the outcomes of the panels.

Alongside PHAR President Dr. Michael Broder, two senior researchers from the pharmaceutical industry will provide their perspective on leading these panels (including why sometimes it’s recommended they are blinded to all aspects), their experience participating in the discussions, and how they have used the results.

Key Topics Include:

  • Overview of the different ways to obtain consensus from expert clinicians
  • The broad steps involved in conducting a RAND/UCLA modified Delphi panel method
  • The possible outcomes of such a panel
  • Benefits and challenges of this method


Michael Broder, MD, MSHS

Partnership for Health Analytic Research (PHAR)

Dr. Michael Broder has 30 years' experience in health economic and outcomes research. He has conducted dozens of expert panels on a wide variety of topics. In addition to being an experienced health services researcher, he is a board-certified physician and provides clinical expertise for many studies at PHAR.

Kathleen Villa, MS

Executive Director, Medical Evidence Generation
Medical Affairs
Ionis Pharmaceuticals

Kathleen Villa is the Executive Director, Medical Evidence Generation at Ionis, where she ensures that healthcare professionals have the evidence they need to make well-informed treatment decisions. Kathleen has 20+ years of experience in the pharma industry, with expertise in observational research, health economics, PROs, and strategic evidence plans.

Tiffany Quock, PhD, MS

Vice President
Health Economics and Outcomes Research
Crinetics Pharmaceuticals

Tiffany P. Quock, PhD, MS is an epidemiologist and health economist by training, with nearly 20 years of experience in HEOR, RWE, and Global Value and Access. She is currently the Vice President, Health Economics and Outcomes Research at Crinetics Pharmaceuticals, a San Diego based pharmaceuticals company.

Production Partner

Additional Content From Partnership for Health Analytic Research (PHAR)

Related Content

The role of patient-centric technologies & tokenization in RWE studies

The role of patient-centric technologies & tokenization in RWE studies

Join the Castor team on the 3rd May 2023 with Aaron Berger from UBC & Ryan Moog from Datavant where we will dive deep into all things RWE, patient-centric technologies and the role of tokenization in clinical trials. You will hear about RWE case studies from the experts, learn new trends in the adoption of DCTs and how the role of patient-centric technologies & tokenization can contribute to successful RWE studies.